|
|
|
|
|
|
Products Description |
|
|
Product name |
Diabinil
|
Composition
|
Each tablet contains :
Glibenclamide 5 mg.
|
Indications |
-
Diabinil (glibenclamide) increase risk of hypoglycemia if concomitantly
administered with NSAIDs chloramphenicol guanethidine, monoaminoxidase
inhibitors, probenecid, salicylates, beta-adrenergic blocking agents and
sulfonamides.
-
Diabinil
(glibenclamide) increased hyperglycemia if concomitantly administered with
corticosteroids, phenothiazines, nicotinic acid, sympathomimmetics, calcium
channel blockers, phenytoin, thiazide and other diuretics, isoniazid, thyroid
hormones, oral contraceptives and estrogens.
|
Dosage & Administration
|
-
Diabinil (glibenclamide) increase risk of hypoglycemia if concomitantly
administered with NSAIDs chloramphenicol guanethidine, monoaminoxidase
inhibitors, probenecid, salicylates, beta-adrenergic blocking agents and
sulfonamides.
-
Diabinil
(glibenclamide) increased hyperglycemia if concomitantly administered with
corticosteroids, phenothiazines, nicotinic acid, sympathomimmetics, calcium
channel blockers, phenytoin, thiazide and other diuretics, isoniazid, thyroid
hormones, oral contraceptives and estrogens.
|
Presentation |
Diabinil
5 mg pack of 2 blister X 10 tablets.
Hospital packs of different size. |
|
|
|
|
|
|
|
Copyright © 2008 biopharm-ye. All rights reserved |
|
|
|